The Board of Directors of Bafna Pharmaceuticals Ltd at its meeting held on January 13, 2012, has approved the revised facilities offered by State Bank of india, Leather & international Branch, Chennai.
The Board also allotted 9,00,000 Equity Shares of Rs. 10/- each at a premium of Rs. 40/- and 25,00,000 warrants convertible into 25,00,000 equity shares of Rs. 10/- each at a premium of Rs. 40/- pursuant to In-principle approval received from the Stock Exchange.
The Bafna Pharmaceuticals stock closed the day at Rs.42, up by Rs.1.70 or 4.22%. The stock hit an intraday high of Rs.42 and low of Rs.40.55.
The total traded quantity was 0.49 lakhs compared to 2 week average of 0.30 lakhs.